Molecular modelling evaluation of the cytotoxic activity of podophyllotoxin analogues

Podophyllotoxin and its structural derivatives, a class of tubulin polymerization inhibitors, have been the objective of numerous studies to prepare better and safer anti-cancer drugs. A library of podophyllotoxin analogues has been designed consisting of 154 analogues. Their molecular interactions and binding affinities with tubulin protein (1SA1) have been studied using the docking-molecular mechanics based on generalized Born/surface area (MM-GBSA) solvation model. Quantitative structure activity relationships were developed between the cytotoxic activity (pIC50) of these compounds and molecular descriptors like docking score and binding free energy. For both the cases the r2 was in the range of 0.642–0.728 indicating good data fit and rcv2 was in the range of 0.631–0.719 indicating that the predictive capabilities of the models were acceptable. In addition, a linear correlation was observed between the predicted and experimented pIC50 for the validation data set with correlation coefficient r2 of 0.806 and 0.887, suggesting that the docked structure orientation and the interaction energies are reasonable. Low levels of root mean square error for the majority of inhibitors establish the docking and Prime/MM-GBSA based prediction model as an efficient tool for generating more potent and specific inhibitors of tubulin protein by testing rationally designed lead compounds based on podophyllotoxin derivatization.

[1]  M. Gordaliza,et al.  Antineoplastic and Antiviral Activities of Podophyllotoxin Related Lignans , 1994, Archiv der Pharmazie.

[2]  M. Gordaliza,et al.  PREPARATION OF TRIOLS AND ETHERS RELATED TO PODOPHYLLOTOXIN , 1994 .

[3]  M. Gordaliza,et al.  Lignans from Juniperus sabina , 1990 .

[4]  J. Loike,et al.  Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners. , 1978, Cancer research.

[5]  H. Broughton,et al.  Bioactive isoxazoline and oxime derivatives from 7-ketolignans , 1997 .

[6]  J. Loike,et al.  Conformational analysis of podophyllotoxin and its congeners. Structure--activity relationship in microtubule assembly. , 1979, Journal of medicinal chemistry.

[7]  K. Lee,et al.  Site-specific DNA cleavage by Cu(II) complexes of podophyllotoxin derivatives. , 1994, Biochemical pharmacology.

[8]  M. Gordaliza,et al.  In vivo immunosuppressive activity of some cyclolignans , 1997 .

[9]  M. Gordaliza,et al.  Synthesis and evaluation of pyrazolignans. A new class of cytotoxic agents. , 1995, Bioorganic & medicinal chemistry.

[10]  N. Farnsworth,et al.  Potential anticancer agents II: antitumor and cytotoxic lignans from Linum album (Linaceae). , 1975, Journal of Pharmacy and Science.

[11]  J. Snyder,et al.  Biochemistry and physiology of microtubules. , 1976, Annual review of biochemistry.

[12]  M. Gordaliza,et al.  Antitumor properties of podophyllotoxin and related compounds. , 2000, Current pharmaceutical design.

[13]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[14]  M. Gordaliza,et al.  Acetylated lignans from Juniperus sabina , 1989 .

[15]  E. Hamel,et al.  Effects of inhibitors of tubulin polymerization on GTP hydrolysis. , 1981, The Journal of biological chemistry.

[16]  Paul D Lyne,et al.  Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. , 2006, Journal of medicinal chemistry.

[17]  H. Itokawa,et al.  4-Aza-2,3-dehydro-4-deoxypodophyllotoxins: simple aza-podophyllotoxin analogues possessing potent cytotoxicity. , 2000, Bioorganic & medicinal chemistry letters.

[18]  D. A. Whiting,et al.  Ligans and neolignans , 1985 .

[19]  E. Hamel.  Antimitotic natural products and their interactions with tubulin , 1996, Medicinal research reviews.

[20]  H. Stähelin,et al.  Synthesis and antimitotic activity of glycosidic lignan derivatives related to podophyllotoxin. , 1971, Journal of medicinal chemistry.

[21]  R. Margolis,et al.  Opposite end assembly and disassembly of microtubules at steady state in vitro , 1978, Cell.

[22]  A. McPhail,et al.  Antitumor agents. 139. Synthesis and biological evaluation of thiocolchicine analogs 5,6-dihydro-6(S)-(acyloxy)- and 5,6-dihydro-6(S)-[(aroyloxy)methyl]-1,2,3-trimethoxy-9-(methylthio)-8H- cyclohepta[a]naphthalen-8-ones as novel cytotoxic and antimitotic agents. , 1993, Journal of medicinal chemistry.

[23]  B. Bhattacharyya,et al.  Podophyllotoxin as a probe for the colchicine binding site of tubulin. , 1977, The Journal of biological chemistry.

[24]  M. Gordaliza,et al.  Selective cytotoxic cyclolignans , 1995 .

[25]  M. Gordaliza,et al.  Antineoplastic and Antiviral Activities of Some Cyclolignans , 1993, Planta Medica.

[26]  H. Rosenkranz,et al.  Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents. , 1996, Bioorganic & medicinal chemistry.

[27]  P. Loehrer.  Etoposide therapy for testicular cancer , 1991, Cancer.

[28]  E. Polak,et al.  Note sur la convergence de méthodes de directions conjuguées , 1969 .

[29]  M. Schnabelrauch,et al.  New synthetic siderophores and their beta-lactam conjugates based on diamino acids and dipeptides. , 2002, Bioorganic & medicinal chemistry.

[30]  Hege S. Beard,et al.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.